FDA defends increased use of guidance in new report to Congress

The FDA is defending its increased use of non-binding guidance documents rather than legally-enforceable rulemakings, arguing that guidance can better keep pace with the latest …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Kuros Biosciences Expands into Extremities Markets – Biotech Investments

Kuros Biosciences AG / Key word(s): Miscellaneous/Personnel Kuros Biosciences Expands into Extremities Markets 19.11.2024 / 07:00 CET/CEST Commercial Highlights Appointment of Jantzen Cole as Vice

November 20, 2024

Scientists just discovered a new genetic clue for delaying Alzheimer’s disease. It’s already inspiring drug discovery

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 21, 2024

Sjogren’s Without Dryness? Yes, It’s a Thing

More than 10% of patients diagnosed with primary Sjögren’s syndrome at a French referral center reported little to no dryness in the mouth or eyes,

October 31, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.